POINTS ABOUT
DRUGS medpgnotes
POINTS ABOUT DRUGS
www.medpgnotes.com
1
Contents ANTICHOLINESTERASE .................................................................................................................................................................................................................................. 2
AUTACOIDS .......................................................................................................................................................................................................................................................... 2
BETA BLOCKERS ................................................................................................................................................................................................................................................ 2
BISPHOSPHONATES ......................................................................................................................................................................................................................................... 2
CATARACT NUGGETS ....................................................................................................................................................................................................................................... 3
CONDITION AND SPECIFIC DRUG ............................................................................................................................................................................................................... 4
CONDITION AND SPECIFIC SURGERY ....................................................................................................................................................................................................... 5
DIABETES NUGGETS ........................................................................................................................................................................................................................................ 6
DIFFERENT USAGE OF DRUGS ..................................................................................................................................................................................................................... 7
DRUG OF CHOICE ............................................................................................................................................................................................................................................... 7
DRUG KINETICS ............................................................................................................................................................................................................................................... 11
FEW DRUG INTERACTIONS ........................................................................................................................................................................................................................ 11
MECHANISM OF ACTION OF DRUGS ....................................................................................................................................................................................................... 12
MONOCLONAL ANTIBODIES ...................................................................................................................................................................................................................... 19
NITRATES NUGGET ....................................................................................................................................................................................................................................... 19
OPIOID NUGGET .............................................................................................................................................................................................................................................. 20
PRODRUGS ........................................................................................................................................................................................................................................................ 20
SAFEST DRUGS IN PREGNANCY NUGGET ............................................................................................................................................................................................. 21
STEROID DRUGS ............................................................................................................................................................................................................................................. 21
TREATMENT OF CHOICE ............................................................................................................................................................................................................................. 22
POINTS ABOUT DRUGS
www.medpgnotes.com
2 ANTICHOLINESTERASE
ANTICHOLINESTERASE Naturally occurring Anticholinesterase Lipid Soluble Anticholinesterase Blood brain barrier crossing Anticholinesterase
Physostigmine
Anticholinesterase used in Myasthenia Gravis Neostigmine/Pyridostigmine
Anticholinesterase used for Diagnosis of Mtasthenia Gravis
Edrophonium
Anticancer showing Anticholinesterase Property Irinotecan
AUTACOIDS FUNCTION AUTAOIDS
Most Important chemical elevating Hypothalamic setpoint
PGE2
Vasoconstrictor PGF2
Prostaglandins causing Renal Vasodilataion PGI2,PGE2
Vasodilatation in blood vessels PGI2,PGE2,PGF2α
Platelet Aggregation TXA2
Inhibition of Platelet aggregation PGI2
Chemotactic LTB4
Bronchoconstrictor Slow reacting substance of anaphylaxis(SRSA)
LTC4 LTD4 LTE4
BETA BLOCKERS Most Cardioselective Vasodilator Property
Nebivolol
K+ Blocking Property Sotalol
K+ Opening Property Tilsolol
Selective β2 blocker Butoxamine
Non Catecholamine acting selectively on β Prenalterenol
BISPHOSPHONATES 1
st Bisphosphonate Approved Etindronate
Treatment of Postmenopausal Osteoporosis Alendronate Risendronate
Prevention of Steroid Induced Osteoporosis Risendronate
Unique Administration Technique Once Yearly i.v/Once Monthly Oral
Zolendronate Idandronate
Most Potent Drug for Treatment & Prevention of Osteoporosis
Bisphosphonates
POINTS ABOUT DRUGS
www.medpgnotes.com
3 CATARACT NUGGETS
CATARACT NUGGETS Anterior Polar Perforation of corneal ulcer
Anterior Capsular Vossious ring
Anterior Subscapular Glaucoma
Posterior Polar Mittendorf dot
Posterior Capsular
Posterior Subcapsular Steroid
MC cause of blindness in India Cataract
MC cause of blindness in Adults Cataract
MC cause of blindness in children Keratomalacia
MC cause of cataract Age Related
MC Type of Congenital Cataract Punctate cataract
MC Health Disorder among Geriatrics Visual Impairment/Cataract
MC visually significant Congenital cataract Lamellar/Zonular cataract
Lens changes in Anterior Uveitis Complicated Cataract with Posterior Capsular Opacities
Second Sight Nuclear Cataract
Fluctuation of Refractory Error Diabetic Cataract
Complication of Intumescent Cataract Phacomorphic Glaucoma
Complication of Morgagnian cataract Phacolytic Glaucoma
Complication of Hypermature Sclerotic Cataract Subluxation/Dislocation of Lens Phacoanaphylactic Uveitis
Cataract in Galactosemia is due to accumulation of Galactitiol
Cataract in Diabetes due to accumulation of Sorbitol
Galactosemia Oil Drop Cataract
MC Ocular Complication of Systemic Steroid Cataract
SPECIFIC CATARACT
Snow Flake Cataract Diabetes Mellitus
Sunflower Cataract Wilson’s disease Chalcosis Penetrating trauma
Vossious ring on anterior surface of lens Rossette Shaped Cataract
Blunt Trauma
Christmas Tree cataract Myotonica Dystrophica
Oil drop Cataract Galactosemia
Morgagnian Cataract Hypermature Senile Cataract
Rainbow cataract Breadcrumb Cataract Polychromatic Lusture
Complicated Cataract
Snow Blindness Ultraviolet
Glass Blower’s Cataract Infrared